Speaking at the British Pharmacological Society’s Summer Meeting in Edinburgh, Dr Robert Williams will argue that, while much more research needs to be done, there is mounting evidence that certain flavanoids – chemicals found in plants and food derived from plants – might provide therapeutic benefit for Alzheimer’s sufferers.
However, a new concept is emerging that suggests flavonoids do not act simply as antioxidants but exert their biological effects through other mechanisms. A small number of recent studies carried out in models of Alzheimer’s disease have found that oral administration of green tea flavanoids or grape flavanoids reduces brain pathology and, in some cases, improves cognition. Dr Williams and colleagues have focused their own cellular studies on a flavanoid called epicatechin, which is abundant in a number of foodstuffs, including cocoa.
“We have found that epicatechin protects brain cells from damage but through a mechanism unrelated to its antioxidant activity and shown in laboratory tests that it can also reduce some aspects of Alzheimer’s disease pathology.
“The challenge now is to identify the single flavonoid or combination of flavonoids that exert the most positive effects and to define the mechanisms of action and optimal quantity required before embarking on clinical trials to treat their effectiveness in dementia.”
No comments:
Post a Comment